1,106 material Form 8-K filings that 909 companies we cover made with the SEC in June 2026, each read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). All of them were written later, when past filings were added: a selection, not every 8-K of the month (see the note below).
BlackRock filed a prospectus supplement and a legal opinion covering up to 12,035,866 common shares that could be issued to holders of Subco Class B-2 units upon redemption. The shares relate to the HPS Investment Partners acquisition, with 7,606,927 issuable on existing units and up to 4,428,939 tied to future deferred consideration. Because the filing registers shares that may be issued later, it could add to the number of shares outstanding over time.
Up to 12,035,866 shares of common stock registered for issuance to Class B-2 SubCo Unit holders
7,606,927 shares relate to units issued as closing consideration for the HPS Transaction, which closed July 1, 2025
Up to 4,428,939 shares relate to deferred consideration units that may be issued subject to post-closing conditions and financial milestones
Filing made June 30, 2026 under an existing automatic shelf registration statement (File No. 333-286025)
Alpex Acquisition Corporation, a blank check company, said holders of 11,500,000 units sold in its initial public offering may separately trade the Class A ordinary shares, warrants and rights starting on or about July 7, 2026. Units that are not separated will keep trading under the symbol ALPXU, so shareholders can choose how to hold each component.
Separate trading of Class A ordinary shares, warrants and rights begins July 7, 2026, per the press release
Separated components will trade on Nasdaq as ALPX, ALPXW and ALPXR; unseparated units remain ALPXU
Holders must have their brokers contact transfer agent VStock Transfer LLC to separate units
D. Boral Capital LLC was sole book-running manager; the Form S-1 was declared effective June 24, 2026
Cantor Equity Partners I, Inc. (CEPO) has postponed the extraordinary general meeting where shareholders will vote on its proposed business combination with BSTR Holdings, Inc. to 10:00 a.m. Eastern on July 10, 2026. The deadline for Class A shareholders to submit shares for redemption was extended to 5:00 p.m. Eastern on July 8, 2026, and the proposed resolutions are unchanged. The meeting has now been moved twice, which pushes back the timing of the vote on the deal.
Meeting moved from July 2, 2026 to 10:00 a.m. Eastern on July 10, 2026, after an earlier postponement from June 26, 2026.
Redemption deadline for Class A ordinary shares extended to 5:00 p.m. Eastern on July 8, 2026.
Proposed business combination with BSTR Holdings, Inc.; record date remains June 5, 2026 and proposed resolutions are unchanged.
At its June 26, 2026 annual meeting, American Eagle Outfitters stockholders approved an amended and restated 2023 Stock Award and Incentive Plan. The amendment adds 9,680,000 shares, extends the plan's term from 2033 to 2036, and raises the non-employee director award limit from $750,000 to $1,000,000. The added share pool gives the company more room for equity awards, which affects how much stock is available to be granted.
The 2023 Plan adds 9,680,000 shares and its term is extended from 2033 to 2036.
The non-employee director award limit rises from $750,000 to $1,000,000.
Jay L. Schottenstein was elected Class I director with 121,484,517 votes for and 18,267,830 against.
The plan amendment passed with 134,900,287 votes for and 4,853,755 against; EY was ratified with 143,082,504 votes for.
At its June 26, 2026 annual meeting, United Therapeutics shareholders approved the 2026 Stock Incentive Plan, which adds 1,500,000 new shares to the pool along with shares left unused under the prior 2015 plan. The plan passed with 25,872,075 votes for and 10,070,290 against, and it lets the company grant options, restricted stock, RSUs and other awards, which can increase the number of shares outstanding over time.
The 2026 Plan received 25,872,075 votes for, 10,070,290 against, 276,512 abstentions and 1,194,857 broker non-votes.
The plan covers 1,500,000 new shares plus 2,413,730 shares remaining under the prior plan as of June 26, 2026.
Shareholders also ratified Ernst & Young LLP as independent auditor for 2026, with 35,753,887 votes for and 1,647,415 against.
Each of the 12 director nominees received more votes for than against, and each serves a one-year term.
GD Culture Group Limited's 1-for-250 reverse stock split took effect June 29, 2026, and its common stock began trading on the Nasdaq Capital Market on a split-adjusted basis under the symbol GDC. The filing says issued and outstanding common shares fell from about 1.04 billion to about 4.16 million, plus shares issued for fractional interests. The company states the split does not alter any stockholder's percentage interest, except for adjustments from rounding up fractional shares.
Reverse split effective at market open on June 29, 2026; new CUSIP 19200A303
Issued and outstanding common shares reduced from about 1.04 billion to about 4.16 million, plus fractional-share adjustments
Board authorized the split by unanimous written consent on June 16, 2026; Certificate of Change filed with Nevada on June 18, 2026
Stockholders approved a split ratio between 1-for-2 and 1-for-250 at the December 31, 2025 annual meeting
At its June 26, 2026 annual meeting, Security National Financial stockholders elected nine directors and approved a 500,000-share change to the 2022 Equity Incentive Plan, an advisory pay vote, and Deloitte as auditor. The Board also declared a 5% stock dividend on Class A and Class C shares, payable July 17, 2026 to holders of record on July 10, 2026, which would increase holders' share counts without a cash payment.
5% stock dividend on Class A and Class C common stock, issued July 17, 2026 to holders of record as of July 10, 2026
Nine directors elected; Scott M. Quist, Gilbert A. Fuller and Adam G. Quist elected by Class A holders voting separately
Equity plan amendment approved: up to 500,000 shares previously reserved as Class A may be issued as Class C; Deloitte & Touche ratified for fiscal 2026
Company has paid 5% stock dividends each year from 1991 through 2025, except 2020 when stock dividends totaled 7.5%
At its June 25, 2026 annual meeting, Myomo stockholders approved raising the company's authorized common stock to 100,000,000 shares and adding 1,833,000 shares to the 2018 Stock Option and Incentive Plan. Stockholders also elected Paul R. Gudonis and Thomas F. Kirk as Class III directors and approved the other proposals, including an advisory say-on-pay vote. The share increases matter to existing holders because they expand the shares the company can issue, though the filing does not state the prior authorized share count.
Charter amendment raising authorized common stock to 100,000,000 shares took effect on filing with Delaware on June 25, 2026; votes: 20,723,545 for, 3,090,849 against, 146,921 abstain.
Plan amendment adds 1,833,000 shares; votes: 10,815,266 for, 3,676,078 against, 938,413 abstain.
Paul R. Gudonis (15,145,277 for) and Thomas F. Kirk (14,333,271 for) elected as Class III directors with terms expiring in 2029.
Advisory say-on-pay vote: 13,715,583 for, 696,112 against, 1,018,062 abstain; CBIZ CPAs P.C. ratified as auditor for fiscal 2026.
At its June 25, 2026 Annual Meeting, Aligos Therapeutics stockholders approved an amendment to the 2020 Employee Stock Purchase Plan that reserves 500,000 additional shares and removes the plan's automatic annual share-reserve increases through 2030. Stockholders also elected two Class III directors, ratified Ernst & Young LLP as auditor for 2026, and backed an annual frequency for future advisory pay votes.
ESPP amendment reserves 500,000 additional shares and eliminates the evergreen provision, so the reserve will be fixed with no further automatic increases.
Proposal 3 (ESPP amendment) received 2,161,966 votes for, 17,797 against, 1,108 abstentions and 1,613,003 broker non-votes.
Bridget Martell and Carole Nuechterlein were elected as Class III directors, with 2,092,164 and 2,086,481 votes for, respectively.
The Company will hold advisory say-on-pay votes annually, following 2,077,884 stockholder votes for a one-year frequency.
Focus Universal convened its 2026 annual meeting of stockholders on June 19, 2026, but adjourned it without conducting any business because there were not enough votes to constitute a quorum. The meeting will reconvene on August 18, 2026, giving stockholders more time to vote on the proposals in the April 24, 2026 proxy statement.
Annual meeting convened and adjourned on June 19, 2026 without any business conducted due to insufficient votes for a quorum
Meeting reconvenes at 2:00 p.m. Pacific Daylight Time on August 18, 2026 at the company's Monterey Park, California offices
Record date remains April 21, 2026; previously submitted proxies will be voted unless revoked
At its June 18, 2026 annual meeting, Fabric.AI stockholders approved the fifth amendment to the Long-Term Incentive Plan, raising the shares available for awards by 4,600,000 to a total of 5,000,000, and approved all other proposals, including the election of five directors. On June 25, 2026, the board decided that future advisory votes on executive pay will be held every three years, which keeps shareholder input on pay on a set cycle.
Incentive Plan share reserve raised by 4,600,000 to 5,000,000 shares; vote was 746,560 for, 23,549 against, 697 abstaining
Five directors elected for one-year terms: Joshua Silverman, Wayne R. Walker, Sebastian Giordano, Zvi Joseph and Greg Schiffman
Board set say-on-pay votes every three years; next frequency vote is at the 2032 annual meeting unless presented earlier
Stockholders approved Nasdaq Rule 5635(d) share issuances tied to Series J and Series K preferred stock and related warrants, 749,771 for and 16,235 against
Launch One Acquisition Corp. moved its extraordinary general meeting from July 7 to July 10, 2026. The vote covers an amendment to extend its deadline to complete an initial business combination from July 15, 2026 to January 15, 2027, unless the board sets an earlier date. Redemption rights deadline was moved to July 8, 2026, which matters to shareholders deciding whether to redeem their shares.
Meeting moved from Tuesday, July 7, 2026 to Friday, July 10, 2026, at 10:00 a.m. Eastern Time
Proposed extension moves the business combination deadline from July 15, 2026 to January 15, 2027
Shareholder redemption deadline extended to Wednesday, July 8, 2026, at 5:00 p.m. Eastern Time
At its June 25, 2026 annual meeting, Marvell stockholders re-elected all seven director nominees to one-year terms, approved the advisory say-on-pay vote on executive compensation, and ratified Deloitte & Touche LLP as auditor for fiscal 2027. Stockholders did not approve a proposal to implement an independent board chairman. The company also declared a quarterly dividend of $0.06 per share, payable July 30, 2026 to holders of record as of July 10, 2026.
Quarterly dividend of $0.06 per share, payable July 30, 2026 to stockholders of record as of July 10, 2026
Independent board chairman proposal not approved: 215,860,927 for and 369,216,217 against
Say-on-pay proposal approved: 327,552,779 for and 258,555,897 against
Deloitte & Touche LLP ratified as auditor for fiscal year ending January 30, 2027: 706,475,236 for and 2,920,281 against
At its June 25, 2026 annual meeting, IP Strategy Holdings stockholders elected three Class II directors, voted on an amendment to the 2024 Equity Incentive Plan to increase the shares available for issuance, and ratified CBIZ CPAs P.C. as independent registered accounting firm for fiscal 2026. Stockholders representing about 48% of outstanding common shares were present or represented, which constituted a quorum. The filing reports votes but does not state the plan's new share count.
Matthew J. Swann received 118,369 votes for and 12,395 withheld; Jennifer D.H. Stiefel 127,890 for and 2,874 withheld; Andrew M. Varga 128,460 for and 2,304 withheld
Equity plan amendment: 84,914 votes for, 44,684 against, 1,166 abstentions, and 131,599 broker non-votes
At its June 23, 2026 annual meeting, CoStar Group stockholders re-elected all eight director nominees, approved the 2026 Employee Stock Purchase Plan, ratified Ernst & Young LLP as auditor for fiscal 2026, and approved the advisory say-on-pay proposal. The 2026 plan authorizes 2,500,000 new shares and replaces the 2021 plan, which will issue no further shares. The filing reports vote tallies but no financial results.
Say-on-pay advisory vote passed with 71.38% of votes cast in favor (257,665,608 for, 103,277,424 against).
Director nominees received between 93.92% (Louise S. Sams) and 99.50% (Christine M. McCarthy) of votes for.
The 2026 ESPP authorizes 2,500,000 shares of common stock and was approved with 359,953,752 votes for.
Ernst & Young LLP was ratified as independent auditor for the year ending December 31, 2026, with 351,556,365 votes for.
At its June 23, 2026 annual meeting, CarMax shareholders approved an amended and restated 2002 Stock Incentive Plan that adds 1,842,000 shares for equity awards and extends the plan's termination date to June 23, 2036. Shareholders also re-elected the 11 director nominees, ratified KPMG LLP as auditor for fiscal 2027, and approved the advisory pay resolution for named executive officers.
Plan amendment adds 1,842,000 shares, adds a minimum vesting requirement with limited exceptions, bars dividend payments on unvested incentive awards, and extends the termination date from June 27, 2033 to June 23, 2036.
Plan approval vote: 109,927,642 for, 3,724,815 against, 1,666,088 abstaining.
Advisory say-on-pay vote: 107,869,976 for, 5,685,835 against, 1,762,734 abstaining.
KPMG LLP ratified as independent registered public accounting firm for fiscal year 2027 with 124,402,598 votes for and 1,969,402 against.
At its June 18, 2026 annual meeting, Precigen stockholders approved an amendment adding 7 million shares to the 2023 Omnibus Incentive Plan for equity awards. The same meeting re-elected all nine directors, ratified Deloitte & Touche LLP as auditor for fiscal 2026, and approved the non-binding executive pay resolution, so the plan change is the only item that affects the share pool.
Plan amendment approved: 207,056,264 for, 4,996,260 against, 234,326 abstain, with 61,452,809 broker non-votes
All nine directors were elected to one-year terms, including Randal Kirk and Nancy Howell Agee
Deloitte & Touche LLP ratified as independent registered public accounting firm for the fiscal year ending December 31, 2026, with 272,813,907 votes for
At its June 18, 2026 Annual Meeting, PVH stockholders approved amendments to the company's Stock Incentive Plan. The amendments add 1,068,000 shares to the pool available for awards and raise the share-counting factor for full value awards granted on or after June 18, 2026 from 1.6 to 1.72 shares per share underlying the award. Because the change adds to the shares available for employee and director equity grants, it can dilute existing shareholders over time.
Stockholders approved adding 1,068,000 shares of common stock to the Plan's available pool
Full value awards granted on or after June 18, 2026 count as 1.72 shares, up from 1.6 shares
The Plan's total share authorization is 24,493,589 shares and the Plan terminates April 29, 2030
Director awards are capped at $750,000 in total value over any 12-month period
On June 22, 2026, CAVA's compensation committee amended and restated its Executive Severance Plan, limiting eligibility to Executive Leadership Team members and adding conditions such as a signed release, reduced severance pay, and a shorter post-change-in-control standstill period. At the same day's annual meeting, stockholders elected two Class III directors, approved executive pay on an advisory basis, and ratified Deloitte & Touche LLP as auditor for fiscal 2026.
Brett Schulman received 85,651,941 votes for and 882,410 withheld; James D. White received 63,427,817 for and 23,106,534 withheld.
Advisory say-on-pay vote: 75,849,587 for, 10,573,039 against, and 111,725 abstentions.
Severance benefits now require a Release and Restrictive Covenants Agreement submitted within 15 business days of a Covered Termination.
Base salary continuation is reduced dollar-for-dollar by compensation earned from any employer or contractor during the Severance Period; Deloitte ratification received 100,054,705 votes for and 378,617 against.
At its June 18, 2026 annual meeting, Okta's stockholders approved an amendment to the 2017 Equity Incentive Plan that removes the plan's termination date, its automatic annual share increase (evergreen provision), and liberal share recycling for stock options and stock appreciation rights. Stockholders also re-elected Anthony Bates and David Schellhase as Class III directors and ratified Ernst & Young LLP as auditor for the fiscal year ending January 31, 2027.
Stockholders approved the 2017 Equity Incentive Plan amendment: 144,073,135 for, 59,915,901 against, 124,413 abstain
Amendment removes the evergreen provision, which had provided for automatic annual increases to reserved Class A common stock shares
Anthony Bates and David Schellhase elected as Class III directors through the 2029 annual meeting; Ernst & Young LLP ratified as auditor
Advisory say-on-pay vote approved: 154,747,380 for, 49,257,140 against
At its June 22, 2026 annual meeting, Talphera stockholders elected Marina Bozilenko, Joseph Todisco and Mark Wan as Class III directors, ratified BPM LLP as the auditor for 2026, and approved the advisory vote on executive pay. Stockholders also approved amended and restated versions of the 2020 Equity Incentive Plan and the 2011 Employee Stock Purchase Plan, which the company filed as exhibits.
31,436,937 of 51,899,648 eligible shares were represented at the meeting, as of the April 24, 2026 record date.
Marina Bozilenko received 23,303,306 votes for and 400,888 withheld; Joseph Todisco and Mark Wan were also elected to terms ending at the 2029 annual meeting.
The 2020 Equity Incentive Plan was approved with 22,602,504 votes for and 1,068,623 against.
The 2011 Employee Stock Purchase Plan was approved with 23,020,334 votes for and 657,322 against.
At its June 22, 2026 annual meeting, Schrodinger stockholders approved an amendment adding 3,000,000 shares to the 2022 Equity Incentive Plan. They also re-elected three Class III directors for terms ending at the 2029 annual meeting, approved an advisory vote on executive compensation, and ratified KPMG LLP as the auditor for fiscal 2026. The added share pool gives the company more shares for equity awards, which can dilute existing holders.
Equity plan: 3,000,000 additional shares authorized; common stock votes were 32,257,903 FOR and 10,825,547 AGAINST
Directors elected: Richard A. Friesner, Rosana Kapeller-Libermann and Gary Sender, each for a term expiring at the 2029 annual meeting
Executive compensation: non-binding advisory vote approved, with 51,345,375 total shares FOR and 870,926 AGAINST
Auditor: KPMG LLP ratified for the fiscal year ending December 31, 2026, with 61,674,114 total shares FOR and 179,559 AGAINST
At its June 16, 2026 annual meeting, IDEAYA Biosciences stockholders elected three Class I directors, ratified PricewaterhouseCoopers LLP as auditor for 2026, and approved executive compensation in a non-binding vote. The same day, the board named Yujiro S. Hata chairman and Terry Rosen, Ph.D., lead independent director, which sets the board's leadership structure.
Yujiro S. Hata received 70,546,418 votes for and 2,470,077 withheld; M. Garret Hampton, Ph.D., received 56,718,637 for and 16,297,858 withheld
PricewaterhouseCoopers LLP ratified: 82,579,758 for, 141,240 against, 384,840 abstentions
Advisory say-on-pay vote: 64,269,756 for, 8,349,131 against, 397,608 abstentions
Effective June 16, 2026, Hata became Chairman and Terry Rosen, Ph.D., became Lead Independent Director
At its June 18, 2026 annual meeting, Anika Therapeutics stockholders approved an increase of 350,000 shares to the 2017 Omnibus Incentive Plan, raising the reserve from 5,760,000 to 6,110,000 shares, and a 200,000-share increase to the 2021 Employee Stock Purchase Plan, raising its reserve to 400,000 shares. The votes also re-elected three Class III directors and ratified Deloitte & Touche LLP as the independent auditor for fiscal 2026, so shareholders should note the larger pool of shares available for future grants and purchases.
Annual meeting held June 18, 2026; shares representing 84.14% of the voting power entitled to vote were present in person or by proxy.
Revised Seventh Amended Plan approved with 8,013,994 votes for and 1,347,970 against; reserve rises from 5,760,000 to 6,110,000 shares.
ESPP amendment approved with 9,110,892 votes for and 257,394 against; reserve rises from 200,000 to 400,000 shares.
Gary P. Fischetti, John B. Henneman, III and Stephen D. Griffin elected as Class III directors to serve until the 2029 annual meeting.
Translational Development Acquisition Corp. (TDAC) reported the results of redemptions tied to its June 17, 2026 shareholder vote on extending its deadline to complete an initial business combination. Public shareholders redeemed 2,598,697 Class A shares, and holders of 14,651,303 shares chose to keep them, leaving about $156.8 million in the trust account. The vote concerns TDAC's proposed business combination with ProLogium Holding Inc.
Public shareholders redeemed 2,598,697 Class A shares; holders of 14,651,303 shares continued to hold them.
About $156.8 million remains in the trust account after redemptions.
The press release states that 95% of the shares voted were in favor of the extension.
TDAC announced a merger agreement with ProLogium on May 27, 2026; the filing cites a $250 million Minimum Cash condition to closing.
Accenture said it increased its fiscal 2026 share repurchase program by $2 billion, to $7.5 billion in expected repurchases, with all purchases to be completed by August 31, 2026. The company said total planned fiscal 2026 shareholder returns, including dividends, are expected to reach $11.5 billion, and that roughly $1 billion of repurchase capacity would remain under the existing authorization afterward.
Total expected fiscal 2026 share repurchases rise to $7.5 billion, a 62% increase year-over-year
Expected fourth-quarter repurchases total $2.3 billion, including the $2 billion increase and $300 million previously planned
Year-to-date shareholder returns through dividends and buybacks were $8.2 billion; planned fiscal 2026 total is $11.5 billion
Repurchases are to be completed by August 31, 2026; the company will request new Board authorization in September 2026
Lionheart Holdings shareholders approved an amendment extending the deadline to complete a business combination from June 20, 2026 to March 20, 2027, and the company filed the amendment in the Cayman Islands on June 22, 2026. The company also entered non-redemption agreements covering 15,879,072 Class A ordinary shares, in exchange for 3,175,814 additional shares to be issued at the closing of a business combination.
Business combination deadline extended from June 20, 2026 to March 20, 2027
Non-redemption agreements cover an aggregate of 15,879,072 Class A ordinary shares held by unaffiliated institutional investors
Holders to receive 3,175,814 additional Class A ordinary shares upon closing of an initial business combination
Sponsor Lionheart Sponsor, LLC did not enter into non-redemption agreements, contrary to the company's June 10, 2026 filing
At its June 18, 2026 annual meeting, MARA Holdings stockholders approved an amendment adding 18,000,000 shares to the 2018 Equity Incentive Plan, and elected two Class III directors. The filing also shows stockholders ratified PricewaterhouseCoopers as auditor and approved executive compensation on an advisory basis.
Stockholders approved an 18,000,000-share increase to the 2018 Plan, effective June 18, 2026; 83,714,947 shares voted for and 26,423,491 against.
Vicki Mealer-Burke and Douglas Mellinger were elected as Class III directors to serve until the 2029 annual meeting.
Advisory say-on-pay proposal passed with 64,973,538 shares for and 44,975,240 against.
PricewaterhouseCoopers LLP was ratified as independent registered public accounting firm for the year ending December 31, 2026, with 208,334,659 shares for.
At its June 17, 2026 annual meeting, Empire Petroleum stockholders approved a 2026 Stock and Incentive Compensation Plan reserving 1,200,000 shares, and no further awards will be made under the 2024 plan. Stockholders also elected three directors, approved executive pay on an advisory basis, and ratified Grant Thornton LLP as auditor for 2026.
2026 Plan reserves 1,200,000 shares of common stock; no further awards under the 2024 plan
Michael R. Morrisett received 20,291,265 votes for and 878,573 withheld; Vice Admiral Andrew L. Lewis (Ret.) and J. Kevin Vann were also elected
Advisory say-on-pay proposal passed with 20,676,312 votes for and 425,115 against
Holders of 30,408,848 shares (76.44% of outstanding) were present; Grant Thornton ratification received 30,104,778 votes for
On June 22, 2026, People entered a Voting Agreement with Barry Diller, Diane von Furstenberg and Alexander von Furstenberg, who have or may be deemed to have the right to direct voting of about 46.4% of People's outstanding voting power. The agreement requires shares above 48.5% of voting power to be voted in the same proportion as other stockholders, and the Board approved authorization to repurchase an additional 10 million shares, though People is not currently repurchasing shares.
Voting Agreement parties have or may be deemed to have voting control over about 46.4% of People's voting power; shares above 48.5% must vote proportionally with other holders.
The agreement terminates automatically if the parties and their affiliates own less than 30% of voting power or if a change of control occurs.
The Board authorized repurchase of an additional 10 million shares of People Common Stock; People is not currently conducting repurchases.
Christopher Currier was appointed Chief Accounting Officer effective June 16, 2026, succeeding Michael H. Schwerdtman, who retired.
At its June 18, 2026 annual meeting, STAAR Surgical shareholders approved Amendment No. 2 to the company's Omnibus Equity Incentive Plan, increasing the shares reserved for issuance under the plan by 3,900,000. Shareholders also elected all seven director nominees, ratified BDO USA as auditor, and approved the advisory vote on executive compensation. The plan increase adds shares available for equity awards, which can dilute existing shareholders' ownership.
Plan amendment approved: 40,231,475 votes for, 974,989 against, 67,857 abstentions, and 2,406,114 broker non-votes.
All seven directors elected to terms expiring at the 2027 annual meeting; Neal C. Bradsher received 40,776,719 votes for.
BDO USA, P.C. ratified as independent auditor for the fiscal year ending January 1, 2027, with 43,433,234 votes for.
Quorum of 43,680,435 of 49,788,295 outstanding shares as of the April 20, 2026 record date.
CH4 Natural Solutions Corporation, a blank-check company that has not yet acquired a target business, said holders of its IPO units may now separately trade the Class A ordinary shares and warrants. The units will keep trading as MTNE.U, while separated shares and warrants trade as MTNE and MTNE.WS on the NYSE. The filing is administrative and does not change the company's financial position or business plans.
Separate trading of Class A ordinary shares and warrants begins June 22, 2026.
Units not separated continue trading on the NYSE as MTNE.U.
Separated shares and warrants trade on the NYSE as MTNE and MTNE.WS; no fractional warrants will be issued.
Quantum Leap Acquisition Corp, a blank check company, said the Class A ordinary shares and redeemable warrants comprising its units will begin separate trading on the NYSE on or about June 23, 2026, under the symbols QLEP and QLEP WS. The separation happens automatically, and the units (QLEPU) will stop trading, which is a routine administrative step after its May 4, 2026 IPO of 20,000,000 units.
Separate trading of Class A ordinary shares (QLEP) and warrants (QLEP WS) expected on or about June 23, 2026, up from the earlier expected date of June 22, 2026
Each whole warrant entitles the holder to buy one Class A ordinary share at $11.50, subject to adjustment
IPO of 20,000,000 units completed May 4, 2026; A.G.P./Alliance Global Partners was sole book-running manager
Lifeway Foods held its 2026 Annual Meeting of Shareholders on June 17, 2026, with 13,982,124 of 15,281,888 outstanding shares represented. Shareholders backed all eight director nominees, ratified Grant Thornton LLP as auditor for 2026, and approved executive compensation on an advisory basis. CEO Julie Smolyansky also presented slides at the meeting, which the company furnished as Exhibit 99.1.
Seven nominees in Proposal 1 each received more FOR votes than AGAINST votes, ranging from 9,025,055 FOR for Dorri McWhorter to 9,527,494 FOR for Susie Hultquist.
Jason Scher received 8,891,948 FOR votes and 3,837,148 AGAINST votes in Proposal 4.
Shareholders ratified Grant Thornton LLP for the year ending December 31, 2026, with 10,600,831 FOR and 142,402 AGAINST.
The nonbinding advisory vote on executive compensation drew 9,480,869 FOR and 3,347,326 AGAINST, with 1,108,016 broker non-votes.
Centrus Energy stockholders approved a seventh amendment to the company's Section 382 rights agreement at the June 18, 2026 annual meeting. The amendment extends the plan's final expiration date to June 30, 2029 and raises the purchase price per preferred share fraction, which the company says reflects the rise in its Class A common stock price. The company says the plan is intended to preserve its net operating loss carryforwards and other tax benefits for stockholders, and that it was not adopted in response to any effort to acquire control.
Final Expiration Date extended from June 30, 2026 to June 30, 2029.
Purchase price per one one-thousandth of a Series A preferred share increased from $160.38 to $1,143.95.
Stockholders approved the amendment on June 18, 2026 with 7,664,845 votes for and 853,077 against.
Yanhong Dai appointed principal accounting officer effective June 18, 2026, with a $250,000 base salary; Todd M. Tinelli remains CFO.
At its annual meeting, Protagonist Therapeutics stockholders approved the company's 2026 Equity Incentive Plan, which replaces the 2016 plan and adds 650,000 new shares for future awards. Stockholders also re-elected two Class I directors and approved the other proposals, including a non-binding say-on-pay vote and the ratification of Ernst & Young LLP as auditor.
2026 Equity Incentive Plan approved, adding 650,000 new shares plus returned shares from the 2016 plan
Dinesh V. Patel, Ph.D., received 48,714,702 votes for and Lewis T. "Rusty" Williams, M.D., Ph.D., received 45,371,193 votes for
Non-binding say-on-pay proposal approved with 53,412,559 votes for and 3,164,702 against
Ernst & Young LLP ratified as independent registered public accounting firm for fiscal year ending December 31, 2026
At its June 16, 2026 annual meeting, Tidewater's stockholders elected seven directors to one-year terms, approved a 2,250,000-share increase to the 2021 Stock Incentive Plan, and approved executive pay in an advisory vote. The filing reports routine governance outcomes with no change in financial results or guidance, but the larger plan share reserve adds potential future equity dilution for shareholders.
Seven directors elected, including Melissa Cougle, Dick H. Fagerstal, Quintin V. Kneen, Louis A. Raspino, Robert E. Robotti, Kenneth H. Traub and Lois K. Zabrocky
Stockholders approved a First Amendment increasing shares available under the 2021 Stock Incentive Plan by 2,250,000, effective June 16, 2026
Shareholders represented 44,546,831 of 49,729,815 eligible shares (89.57%); PricewaterhouseCoopers LLP ratified as auditor for fiscal 2026
At its June 16, 2026 annual meeting, Lakeland Industries stockholders approved the 2026 Equity Incentive Plan, elected three Class I directors, ratified RSM US LLP as independent auditor, and approved executive pay on an advisory basis. The plan's full terms were described in the company's May 7, 2026 proxy statement and are filed as Exhibit 10.1. The filing does not report financial results.
The board adopted the 2026 Equity Incentive Plan on May 5, 2026, and stockholders approved it at the June 16, 2026 annual meeting.
Ronald Herring, Melissa Kidd and Lee D. Rudow were elected as Class I directors, with terms expiring at the 2029 annual meeting.
RSM US LLP was ratified as auditor for the fiscal year ending January 31, 2027, with 8,657,801 votes for.
Advisory say-on-pay proposal passed with 6,064,126 votes for and 131,088 against.
Forefront Tech Holdings Acquisition Corp, a blank check company, said holders of its units may elect to separately trade Class A ordinary shares and warrants starting June 22, 2026. The units will continue to trade under FTHAU, while separated shares and warrants will trade as FTHA and FTHAW on Nasdaq. The change is administrative and does not alter the terms of the shares or warrants, which carry an $11.50 exercise price per share.
Separate trading of Class A ordinary shares (FTHA) and warrants (FTHAW) begins June 22, 2026
Each unit consists of one Class A ordinary share and one-half of one redeemable warrant
Each whole warrant entitles the holder to buy one Class A ordinary share at $11.50
Holders must have brokers contact transfer agent Odyssey Transfer and Trust Company to separate units
At its June 18, 2026 annual meeting, Agios stockholders approved an amendment adding 2,000,000 shares to the 2023 Stock Incentive Plan, with the same increase for incentive stock options. Stockholders also re-elected Class I directors Rahul Ballal, Brian Goff and Cynthia Smith, approved the advisory pay vote for named executive officers, and ratified PricewaterhouseCoopers LLP as auditor. The larger share reserve gives the company more shares available for equity awards.
2,000,000 additional shares added to the 2023 Stock Incentive Plan; 43,549,751 votes for and 2,527,678 against the amendment
Class I directors elected for three-year terms expiring at the 2029 annual meeting: Rahul Ballal, Ph.D., Brian Goff and Cynthia Smith
Smith received 31,496,376 votes for and 14,592,704 withheld, the lowest support of the three director nominees
PricewaterhouseCoopers LLP ratified as independent registered public accounting firm, with 48,511,213 votes for
At its June 12, 2026 annual meeting, MultiSensor AI stockholders elected five directors, ratified Weaver and Tidwell L.L.P. as auditor for 2026, and approved a 500,000-share increase to the 2023 Incentive Award Plan, bringing the total to 661,012 shares. The plan amendment took effect on June 12, 2026, and it raises the pool of shares available for employee and director equity awards, which can dilute existing holders.
Plan amendment adds 500,000 shares, bringing the total issuable under the 2023 Incentive Award Plan to 661,012 shares; effective June 12, 2026
Proposal 3 approved with 786,276 votes for, 142,330 against, 3,335 abstentions and 374,345 broker non-votes
Shares present or represented totaled 1,306,286, about 64.686% of outstanding common stock as of the April 14, 2026 record date
All five nominees elected, including Margaret Chu (908,326 votes for) and Petros Kitsos (853,273 votes for)
Solitario Resources Corp. held its annual shareholder meeting on June 17, 2026, where all six director nominees were elected, shareholders approved the advisory executive compensation resolution, and Sadler, Gibb & Associates was ratified as auditor for fiscal 2026. The votes are routine governance outcomes, and the company disclosed them in a press release furnished as Exhibit 99.1.
Six directors elected; John Labate received 38,367,832 votes for, with 255,761 withheld.
Advisory vote on executive compensation: 37,403,628 shares for (96.84% of shares voting), 574,407 against, 645,555 abstaining.
Auditor appointment ratified: 51,036,820 shares for (98.70% of shares voting), 122,148 against, 548,380 abstaining; Assure CPA merged with and was succeeded by Sadler, Gibb & Associates effective June 3, 2026.
Keystone Acquisition Corp., a blank check company, said holders of its units may separately trade Class A ordinary shares and warrants starting on or about June 22, 2026. Units not separated will keep trading under KEYYU, while the shares and warrants will trade under KEYY and KEYYW. The filing is administrative and does not describe a business combination or change in the company's financial position.
Separate trading of Class A ordinary shares and warrants begins on or about June 22, 2026.
Each unit consists of one Class A ordinary share and one-half of one redeemable warrant.
The initial public offering of 28,750,000 units, including 3,750,000 units from full exercise of the overallotment option, was completed on June 4, 2026.
Holders must have their brokers contact Efficiency INC., the transfer agent, to separate units.
The Trust said it intends to make quarterly cash distributions from net income generated by staking its AVAX, and that the first distribution is expected in July 2026. The Trust may sell staking rewards or some AVAX to fund payments, which could affect AVAX exposure and the share price or net asset value.
Distributions will be made at least quarterly and consist of net staking income after service provider and custodian fees.
The Trust's initial distribution is expected in July 2026; record date, payment date and amount will be announced by the Sponsor.
The Trust may sell staking rewards and/or a portion of its AVAX to fund distributions.
Amount is not assured and depends on staking rewards, regulatory requirements and operational and liquidity needs.
At its June 17, 2026 annual meeting, Acrivon Therapeutics stockholders approved an amended and restated 2022 Equity Incentive Plan that adds 3,000,000 shares, bringing the total reserve to 8,606,723 shares. They also re-elected two Class I directors, ratified PricewaterhouseCoopers LLP as auditor for 2026, and the plan's share reserve will rise automatically each January 1 through 2032. The plan allows equity awards to employees, non-employee directors and consultants, so the larger reserve affects the potential share count for existing holders.
Equity plan: total reserve of 8,606,723 shares, including a 3,000,000-share increase; approved with 20,546,400 for and 3,757,400 against
Annual automatic increase on January 1 through 2032 equal to 5% of fully diluted shares outstanding (including pre-funded warrants) at the prior December 31, unless the Board sets a lower amount
Directors: Michael Tomsicek (24,020,408 for) and Charles Baum (23,657,074 for) elected as Class I directors until the 2029 annual meeting
Quorum of 31,336,993.43 shares, or 73.21% of shares entitled to vote as of the April 23, 2026 record date
At its June 17, 2026 annual meeting, Ascent Solar stockholders approved raising the share count under its 2023 Equity Incentive Plan from 893,611 to 1,700,000 shares and re-elected two Class A directors to three-year terms ending in 2029. The filing also shows approval of the auditor ratification and the advisory vote on executive compensation.
The 2023 Equity Incentive Plan share limit rises from 893,611 to 1,700,000 shares.
Louis Berezovsky and Forrest Reynolds were elected as Class A directors, each with a term ending in 2029.
Haynie & Company ratification received 5,286,724 FOR votes; the say-on-pay proposal was approved.
At its June 16, 2026 annual meeting, Twilio stockholders approved amended and restated versions of the 2016 Stock Option and Incentive Plan and the 2016 Employee Stock Purchase Plan, and re-elected four Class I directors. Stockholders also ratified KPMG LLP as the independent auditor for fiscal 2026. The equity plan approval drew 30,250,610 votes against, a meaningful share of the votes cast, though it passed.
Equity plan approved: 88,949,992 for, 30,250,610 against, 91,571 abstain, 11,845,816 broker non-votes
Employee Stock Purchase Plan approved: 118,850,839 for, 398,239 against, 43,095 abstain
Directors elected to serve until the 2027 annual meeting: Charles Bell, Jeffrey Immelt, Douglas Robinson, Erika Rottenberg
Holders of 131,137,989 Class A shares, 86.40% of voting power, attended, establishing a quorum; record date April 17, 2026
At its June 11, 2026 annual meeting, Insight Molecular Diagnostics shareholders approved an amendment adding 1,750,000 shares to its equity incentive plan, bringing the total authorized to 5,550,000 shares. All four director nominees were re-elected, and the shareholders also ratified CBIZ CPAs P.C. as auditor and approved executive pay on an advisory basis. The filing reports routine annual meeting outcomes and does not describe any change in leadership or finances.
Plan amendment approved: 19,117,865 votes for, 122,829 against, 4,799 abstained
Total shares authorized under the Incentive Plan rises to 5,550,000 from 3,800,000 (1,750,000 added)
Four directors elected to serve until the 2027 annual meeting: Joshua Riggs, Andrew Arno, Andrew J. Last and Louis E. Silverman
The blank check company said holders of its GRAIL securities may elect to separately trade the Class A ordinary shares and warrants starting June 22, 2026. Holders must have their brokers contact Continental Stock Transfer & Trust Company to separate the units; unseparated securities continue to trade under GCGRU.
Separate trading of Class A ordinary shares (GCGR) and warrants (GCGRW) begins June 22, 2026
Each GRAIL Security consists of one Class A ordinary share and one-fourth of one warrant
Unseparated GRAIL Securities continue to trade on Nasdaq under GCGRU; no fractional warrants will be issued
At its June 11, 2026 annual meeting, Ingersoll Rand stockholders approved the 2026 Omnibus Incentive Plan, which took effect on approval, and elected all 10 director nominees to terms expiring at the 2027 annual meeting. Stockholders also ratified Deloitte & Touche LLP as auditor for fiscal 2026 and approved executive compensation on a non-binding basis. The filing contains no financial results, and the votes ran in favor of each proposal.
Plan approval: 353,964,877 votes for and 6,254,223 against, with 299,541 abstentions
Shareholders approved executive compensation on a non-binding basis: 350,614,090 for and 9,557,163 against
Deloitte & Touche LLP ratified as independent registered public accounting firm for fiscal 2026 with 363,304,149 votes for
About 95.3% of the 391,332,297 shares entitled to vote, as of an April 16, 2026 record date, were present in person or by proxy
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Briefs marked “Written later” were written in November 2026 for filings that were by then more than three weeks old, so months before mid-October 2026 hold a selection: every material 8-K of the past year for the 100 largest companies we cover and the last 15 important 8-Ks of every other one. Briefs the number check holds back are not shown or counted. Also: the last 45 days, briefs by company, A–Z and the live SEC filings wire.